chevron_leftBack
As of 15 June 2026, Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. has a market cap of $895.49M USD, ranking #11346 globally and #3270 in China.
It ranks #1023 in the Healthcare sector, and #383 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$895.49MUSD
6.07B CNY
Enterprise Value
$969.58MUSD
6.56B CNY
Revenue (TTM)
$87.12MUSD
590.33M CNY
EBITDA (TTM)
-$237.02KUSD
-1.6M CNY
Net Income (TTM)
-$27.79MUSD
-188.27M CNY
EBITDA Margin
-0.3%
Profit Margin
-32%
PS Ratio
10.3
PB Ratio
2.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jinfang Lou
open_in_new
Employees
1,451
Founded
2011
Website
hzbio-s.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.9% | -3% | 7.5% | 5.6% | -4.4% | 68% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
301096
杭州百诚医药科技股份有限公司 Class A
ISIN: CNE1000056N5
Shares Out.:
Shares Outstanding:
108.451M1
Shares Float:
83.935M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
55.95 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. operates as a pharmaceutical technology research and development and services company in China. The company primarily provides drug research and development services; and the transformation of research and development technology results for various pharmaceutical, as well as pharmaceutical research and development investment companies. Its business covers the principal links of drug discovery, pharmaceutical research, clinical trials, customized research and development and production, and registration applications. The company was incorporated in 2011 and is headquartered in Hangzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
6K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
5K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
3K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
85K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
61K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
40K%
|
97.4
|
|
SIX: RO
|
$321.52B
36K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
32K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
31K%
218.9B CHF
|
20.5
|
chevron_leftBack